Cognitive side-effects of antiepileptic drugs in children

Handbook of Clinical Neurology

Volumn 111, Issue , 2013, Pages 707-718

  Ijff, Dominique M ^a,b   Aldenkamp, Albert P ^a,b  

^a EPILEPSY CENTER KEMPENHAEGHE   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84876782471     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-444-52891-9.00073-7     Document Type: Chapter

References (111)

1. Aarts J.H., Binnie C.D., Smit A.M., et al. Selective cognitive impairment during focal and generalized epileptiform EEG activity. Brain 1984, 107:293-308.
2. Äikiä M., Kälviäinen R., Sivenius J., et al. Cognitive effects of oxcarbazepine and phenytoin monotherapy in newly diagnosed epilepsy: one year follow-up. Epilepsy Res 1992, 11:199-203.
3. Aldenkamp A.P. Cognitive effects of topiramate, gabapentin and lamotrigine in healthy young adults. Neurology 2000, 54:270-272.
4. Aldenkamp A.P. Cognitive and behavioural assessment in clinical trials: when should they be done?. Epilepsy Res 2001, 45:155-159.
5. Aldenkamp A.P. Antiepileptic drug treatment and epileptic seizures - effects on cognitive function. The Neuropsychiatry of Epilepsy 2002, 256-267. Cambridge University Press, New York. M. Trimble, B. Schmitz (Eds.).
6. Aldenkamp A.P., Alpherts W.C.J. The effect of the new antiepileptic drug rufinamide on cognitive functions. Epilepsia 2006, 47:1153-1159.
7. Aldenkamp A.P., Baker G. A systematic review of the effects of lamotrigine on cognitive function and quality of life. Epilepsy Behav 2001, 2:85-91.
8. Aldenkamp A.P., Dodson W.E. Epilepsy and education; cognitive factors in learning behavior. Epilepsia 1990, 31:S9-S20.
9. Aldenkamp A.P., Alpherts W.C.J., Blennow G., et al. Withdrawal of antiepileptic medication - effects on cognitive function in children: The Multicentre Holmfrid Study. Neurology 1993, 43:41-50.
10. Aldenkamp A.P., Dreifuss F.E., Renier W.O., et al. Epilepsy in Children and Adolescents 1995, CRC Press, Boca Raton.
11. Aldenkamp A.P., Mulder O.G., Overweg J. Cognitive effects of lamotrigine as first line add-on in patients with localized related (partial) epilepsy. J Epilepsy 1997, 10:117-121.
12. Aldenkamp A.P., Baker G., Mulder O.G., et al. A multicentre randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 2000, 41:1167-1178.
13. Aldenkamp A.P., Arends J., Overweg-Plandsoen T.C., et al. Acute cognitive effects of nonconvulsive difficult-to-detect epileptic seizures and epileptiform electroencephalographic discharges. J Child Neurol 2001, 16:119-123.
14. Aldenkamp A.P., Arends J., Bootsma H.P., et al. Randomized, double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers. Epilepsia 2002, 43:19-26.
15. Aldenkamp A.P., De Krom M., Reijs R. Newer antiepileptic drugs and cognitive issues. Epilepsia 2003, 44:21-29.
16. American Academy of Pediatrics Behavioral and cognitive effects of anticonvulsant therapy Committee on Drugs. Pediatrics 1985, 76:644-647.
17. Banks G.K., Beran R.G. Neuropsychological assessment in lamotrigine treated epileptic patients. Clin Exp Neurol 1991, 28:230-237.
18. Binnie C.D., van Emde B.W., Kasteleijn-Nolste-Trenite D.G., et al. Acute effects of lamotrigine (BW430C) in persons with epilepsy. Epilepsia 1986, 27:248-254.
19. Blum D., Meador K., Biton V., et al. Cognitive effects of lamotrigine compared with topiramate in patients with epilepsy. Neurology 2006, 67:400-406.
20. Bootsma H.P., Coolen F., Aldenkamp A.P., et al. Topiramate in clinical practice: long-term experience in patients with refractory epilepsy referred to a tertiary epilepsy center. Epilepsy Behav 2004, 5:380-387.
21. Bootsma H.P., Ricker L., Hekster Y.A., et al. The impact of side effects on long-term retention in three new antiepileptic drugs. Seizure 2009, 18:327-331.
22. Bourgeois B.F. Determining the effects of antiepileptic drugs on cognitive function in pediatric patients with epilepsy. J Child Neurol 2004, 19:S15-S24.
23. Brandl U., Kurlemann G., Neubauer B., et al. Seizure and cognitive outcomes in children and adolescents with epilepsy treated with topiramate. Neuropediatrics 2010, 41:113-120.
24. Brodbeck V., Jansen V., Fietzek U., et al. Long-term profile of lamotrigine in 119 children with epilepsy. Eur J Paediatr Neurol 2006, 10:135-141.
25. Burton L.A., Harden C. Effect of topiramate on attention. Epilepsy Res 1997, 27:29-32.
26. Calandre E.P., Dominguez-Granados R., Gomez-Rubio M., et al. Cognitive effects of long-term treatment with phenobarbital and valproic acid in school children. Acta Neurol Scand 1990, 81:504-506.
27. Camfield C.S., Chaplin S., Doyle A.B., et al. Side effects of Phenobarbital in toddlers; behavioural and cognitive aspects. J Pediatr 1979, 95:361-365.
28. Camposano S.E., Major P., Halpern E., et al. Vigabatrin in the treatment of childhood epilepsy: a retrospective chart review of efficacy and safety profile. Epilepsia 2008, 49:1186-1191.
29. Chadwick D.W., Marson T., Kadir Z. Clinical administration of new antiepileptic drugs: an overview of safety and efficacy. Epilepsia 1996, 37:S17-S22.
30. Chen Y.J., Chow J.C., Lee I.C. Comparison the cognitive effect of anti-epileptic drugs in seizure-free children with epilepsy before and after drug withdrawal. Epilepsy Res 2001, 44:65-70.
31. Cohen A.F., Ashby L., Crowley D., et al. Lamotrigine (BW430C), a potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam. Br J Clin Pharmacol 1985, 20:619-629.
32. Coppola G., Verrotti A., Resicato G., et al. Topiramate in children and adolescents with epilepsy and mental retardation: a prospective study on behavior and cognitive effects. Epilepsy Behav 2008, 12:253-256.
33. Craig I., Tallis R. Impact of valproate and phenytoin on cognitive function in elderly patients: results of a single-blind randomized comparative study. Epilepsia 1994, 35:381-390.
34. Curran H.V., Java R. Memory and psychomotor effects of oxcarbazepine in healthy human volunteers. Eur J Clin Pharmacol 1993, 44:529-533.
35. Dodrill C.B., Troupin A.S. Psychotropic effects of carbamazepine in epilepsy: a double-blind comparison with phenytoin. Neurology 1977, 27:1023-1028.
36. Dodrill C.B., Arnett J.L., Sommerville K.W., et al. Cognitive and quality of life effects of differing dosages of tiagabine in epilepsy. Neurology 1997, 48:1025-1031.
37. Dodson W.E., Pellock J.M. Pediatric Epilepsy: Diagnosis and Treatment 1993, Demos Publications, New York.
38. Dodson W.E., Trimble M.R. Epilepsy and Quality of Life 1994, Raven Press, New York.
39. Donati F., Gobbi G., Campistol J., et al. Oxcarbazepine Cognitive Study Group. Effects of oxcarbazepine on cognitive function in children and adolescents with partial seizures. Neurology 2006, 67:679-682.
40. Donati F., Gobbi G., Campistol J., et al. Oxcarbazepine Cognitive Study Group. The cognitive effects of oxcarbazepine versus carbamazepine or valproate in newly diagnosed children with partial seizures. Seizure 2007, 16:670-679.
41. Ettinger A.B., Weisbrot D.M., Saracco J., et al. Positive and negative psychotropic effects of lamotrigine in patients with epilepsy and mental retardation. Epilepsia 1998, 39:874-877.
42. Faught E., Wilder B.J., Ramsay R.E., et al. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosages. Neurology 1996, 46:1684-1690.
43. Forsythe I., Butler R., Berg I., et al. Cognitive impairment in new cases of epilepsy randomly assigned to carbamazepine, phenytoin and sodium valproate. Dev Med Child Neurol 1991, 33:524-534.
44. Fritz N., Glogau S., Hoffmann J., et al. Efficacy and cognitive side effects of tiagabine and topiramate in patients with epilepsy. Epilepsy Behav 2005, 6:373-381.
45. Gaily E., Appelqvist K., Kantola-Sorsa E., et al. Cognitive deficits after cryptogenic infantile spasms with benign seizure evolution. Dev Med Child Neurol 1999, 41:660-664.
46. Gallassi R., Morreale A., Di Sarro R., et al. Cognitive effects of antiepileptic drug discontinuation. Epilepsia 1992, 33:S41-S44.
47. Gillham R., Kane K., Bryant-Comstock L., et al. A double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy with health-related quality of life as an outcome measure. Seizure 2000, 9:375-379.
48. Glauser T.A., Nigro M., Sachdeo R., et al. Ethosuximide, valproic acid and lamotrigine in childhood absence epilepsy. N Engl J Med 2010, 362:790-799.
49. Gomer B., Wagner K., Frings L., et al. The influence of antiepileptic drugs on cognition: A comparison of levetiracetam and topiramate. Epilepsy Behav 2007, 10:486-494.
50. Hamilton M.J., Cohen A.F., Yuen A.W., et al. Carbamazepine and lamotrigine in healthy volunteers: relevance to early tolerance and clinical trial dosage. Epilepsia 1993, 34:166-173.
51. Helmstaedter C., Witt J.A. Cognitive outcome of antiepileptic treatment with levetiracetam versus carbamazepine monotherapy: A non-interventional surveillance trial. Epilepsy Behav 2010, 18:74-80.
52. Ideström C.M., Schalling D., Carlquist U., et al. Acute effects of diphenylhydantoin in relation to plasma levels. Behavioral and psychological studies. Psychol Med 1972, 2:111-120.
53. Jette N.J., Marson A.G., Hutton J.L. Topiramate add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 3 2002, CD001417.
54. Jha S., Kumar V., Mishra V.N. Effect of common anti-epileptic drugs on cognition in schoolchildren with epilepsy. Indian J Physiol Pharmacol 2001, 45:507-510.
55. Kälviäinen R., Äikiä M., Mervaala E., et al. Long-term cognitive and EEG effects of tiagabine in drug-resistant partial epilepsy. Epilepsy Res 1996, 25:291-297.
56. Kang H.C., Eun B.L., Wu Lee C., et al. Korean Pediatric Topiramate Study Group. The effects on cognitive function and behavioral problems of topiramate compared to carbamazepine as monotherapy for children with benign rolandic epilepsy. Epilepsia 2007, 48:1716-1723.
57. Kellet M.W., Smith D.F., Stockton P.A., et al. Topiramate in clinical practice: first year's postlicensing experience in a specialist epilepsy clinic. J Neurol Neurosurg Psychiatry 1999, 66:759-763.
58. Ketter T.A., Post R.M., Theodore W.H. Positive and negative psychiatric effects of antiepileptic drugs in patients with seizure disorders. Neurology 1999, 53:53-67.
59. Laaksonen R., Kaimola K., Grahn-Teräväinen E., et al. A controlled clinical trial of the effects of carbamazepine and oxcarbazepine on memory and attention 1985, Hamburg, [Abstract].
60. Leach J.P., Girvan J., Paul A., et al. Gabapentin and cognition: a double blind, dose ranging, placebo controlled study in refractory epilepsy. J Neurol Neurosurg Psychiatry 1997, 62:372-376.
61. Levisohn P.M., Mintz M., Hunter S.J., et al. Neurocognitive effects of adjunctive levetiracetam in children with partial-onset seizures: a randomized, double-blind, placebo-controlled, noninferiority trial. Epilepsia 2009, 50:2377-2389.
62. Lhatoo S.D., Wong I.C.K., Sander J.W. Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy. Epilepsia 2000, 41:338-341.
63. Loge C., Hunter S.J., Schiemann J., et al. Assessment of behavioral and emotional functioning using standardized instruments in children and adolescents with partial-onset seizures treated with adjunctive levetiracetam in a randomized, placebo-controlled trial. Epilepsy Behav 2010, 18:291-298.
64. MacLeod C.M., Dekaban A.S., Hunt E. Memory impairment in epileptic patients: selective effects of phenobarbital concentration. Science 1978, 202:1102-1104.
65. Mandelbaum D.E., Burack G.D., Bhise V. Impact of antiepileptic drugs on cognition, behaviour, and motor skills in children with newly onset idiopathic epilepsy. Epilepsy Behav 2009, 16:341-344.
66. Marciani M.G., Spanedda F., Bassetti M.A., et al. Effect of lamotrigine on EEG paroxysmal abnormalities and background activity: a computerized analysis. Br J Clin Pharmacol 1996, 42:621-627.
67. Marciani M.G., Stanzione P., Mattia D., et al. Lamotrigine add-on therapy in focal epilepsy: electroencephalographic and neuropsychological evaluation. Clin Neuropharmacol 1998, 21:41-47.
68. Marson A.G., Kadir Z.A., Hutton J.L., et al. The new antiepileptic drugs: a systematic review of their efficacy and tolerability. Epilepsia 1997, 38:859-880.
69. Marson A.G., Kadir Z.A., Hutton J.L., et al. Gabapentin for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2000, CD001415.
70. Marson A.G., Hutton J.L., Leach J.P., et al. Levetiracetam, oxcarbazepine, remacemide and zonisamide for drug resistant localization-related epilepsy: a systematic review. Epilepsy Res 2001, 46:259-270.
71. Martin R., Kuzniecky R., Ho S., et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999, 52:321-327.
72. McKee P.J., Blacklaw J., Forrest G., et al. A double-blind, placebo-controlled interaction study between oxcarbazepine and carbamazepine, sodium valproate and phenytoin in epileptic patients. Br J Clin Pharmacol 1994, 37:27-32.
73. McKee J.R., Sunder T.R., FineSmith R., et al. Lamotrigine as adjunctive therapy in patients with refractory epilepsy and mental retardation. Epilepsy Behav 2003, 4:386-394.
74. Meador K.J. Assessing cognitive effects of a new AED without the bias of practice effects [Abstract]. Epilepsia 1997, 38:60.
75. Meador K.J., Loring D.W., Huh K., et al. Comparative cognitive effects of anticonvulsants. Neurology 1990, 40:391-394.
76. Meador K.J., Loring D.W., Allen M.E., et al. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology 1991, 41:1537-1540.
77. Meador K.J., Loring D.W., Abney O.L., et al. Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia 1993, 34:153-157.
78. Meador K.J., Loring D.W., Ray P.G., et al. Differential cognitive effects of carbamazepine and gabapentin. Epilepsia 1999, 40:1279-1285.
79. Meador K.J., Loring D.W., Ray P.G., et al. Differential effects of carbamazepine and lamotrigine [Abstract]. Neurology 2000, 54:A84.
80. Meador K.J., Loring D.W., Vahle V.J. Cognitive and behavioural effects of lamotrigine and topiramate in healthy volunteers. Neurology 2005, 64:2108-2114.
81. Mervaala E., Koivista K., Hanninen T., et al. Electrophysiological and neuropsychological profiles of lamotrigine in young and age-associated memory impairment (AAMI) subjects [Abstract]. Neurology 1995, 45:A259.
82. Monaco F., Torta R., Cicolin A., et al. Lack of association between vigabatrin and impaired cognition. J Int Med Res 1997, 25:296-301.
83. Mortimore C., Trimble M., Emmers E. Effects of gabapentin on cognition and quality of life in patients with epilepsy. Seizure 1998, 7:359-396.
84. Neyens L.G.J., Alpherts W.C.J., Aldenkamp A.P. Cognitive effects of a new pyrrolidine derivative (levetiracetam) in patients with epilepsy. Prog Neuropsychopharmacol Biol Psychiatry 1995, 19:411-419.
85. Nicolai J., Aldenkamp A.P., Huizinga J.R., et al. Cognitive side-effects of valproate-acid induced hyperammonemia in children with epilepsy. J Clin Psychopharmacol 2007, 27:221-224.
86. Pandina G.J., Ness S., Polverejan E., et al. Cognitive effects of topiramate in migraine patients aged 12 through 17 years. Pediatr Neurol 2010, 42:187-195.
87. Pressler R.M., Binnie C.D., Coleshill S.G., et al. Effect of lamotrigine on cognition in children with epilepsy. Neurology 2006, 66:1495-1499.
88. Prevey M.L., Delaney R.C., Cramer J.A., et al. The Department of Veterans Affairs Epilepsy Cooperative Study 264 Group. Effect of valproate on cognitive function. Comparison with carbamazepine. Arch Neurol 1996, 53:1008-1016.
89. Privitera M., Fincham R., Penry J., et al. Topiramate YE Study Group. Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 600-, 800-, and 1000-mg daily dosages. Neurology 1996, 46:1678-1683.
90. Riva D., Devoti M. Carbamazepine withdrawal in children with previous symptomatic partial epilepsy: effects on neuropsychologic function. J Child Neurol 1999, 14:357-362.
91. Sabers A., Moller A., Dam M., et al. Cognitive function and anticonvulsant therapy: effect of monotherapy in epilepsy. Acta Neurol Scand 1995, 92:19-27.
92. Schubert R. Attention deficit disorder and epilepsy. Pediatr Neurol 2005, 32:1-10.
93. Seidel W.T., Mitchell W.G. Cognitive and behavioural effects of carbamazepine in children: data from benign rolandic epilepsy. J Child Neurol 1999, 14:716-723.
94. Smith W.L., Lowrey J.B. Effects of diphenylhydantoin on mental abilities in the elderly. J Am Geriatr Soc 1975, 23:207-211.
95. Smith D., Baker G., Davies G., et al. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993, 34:312-322.
96. Challenge Epilepsy - New Antiepileptic Drugs 1998, Blackwell Science, Berlin. H. Stefan, G. Krämer, B. Mamoli (Eds.).
97. Sveinbjornsdottir S., Sander J.W., Patsalos P.N., et al. Neuropsychological effects of tiagabine, a potential new antiepileptic drug. Seizure 1994, 3:29-35.
98. Sulzbacher S., Farwell J.R., Temkin N., et al. Late cognitive effects of early treatment with phenobarbital. Clin Pediatr 1999, 38:387-394.
99. Tatum W.O., French J.A., Faught E., et al. Postmarketing experience with topiramate and cognition. Epilepsia 2001, 42:1134-1140.
100. Thomas L., Trimble M. The effects of vigabatrin on attention, concentration and mood: an investigation in healthy volunteers. Seizure 1996, 5:205-208.
101. Thompson P.J., Trimble M.R. Sodium valproate and cognitive functioning in normal volunteers. Br J Clin Pharmacol 1981, 12:819-824.
102. Thompson P.J., Huppert F., Trimble M.R. Anticonvulsant drugs, cognitive function and memory. Acta Neurol Scand 1980, S80:75-80.
103. Thompson P.J., Huppert F.A., Trimble M.R. Phenytoin and cognitive functions: effects on normal volunteers and implications for epilepsy. Br J Clin Psychol 1981, 20:155-162.
104. Thompson P.J., Baxendale S.A., Duncan J.S., et al. Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry 2000, 69:636-641.
105. Trimble M.R. Anticonvulsant drugs and cognitive function: a review of the literature. Epilepsia 1987, 28:37-45.
106. Trimble M.R. Antiepileptic drugs, cognitive function, and behavior in children: evidence from recent studies. Epilepsia 1990, 30:S30-4.
107. Vermeulen J., Aldenkamp A.P. Cognitive side-effects of chronic antiepileptic drug treatment: a review of 25 years of research. Epilepsy Res 1995, 22:65-95.
108. Vining E.P., Mellitis E.D., Dorsen M.M., et al. Psychologic and behavioral effects of antiepileptic drugs in children: a double-blind comparison between phenobarbital and valproic acid. Pediatrics 1987, 80:165-174.
109. Wolf S.M., Forsythe A., Studen A.A., et al. Long-term effect of phenobarbital on cognitive function in children with febrile convulsions. Pediatrics 1981, 68:820-823.
110. Wong I.C. New antiepileptic drugs study suggests that under a quarter of patients will still be taking the new drugs after six years. BMJ 1997, 314:603-604.
111. Wu T., Chen C.C., Chen T.C., et al. Clinical efficacy and cognitive and neuropsychological effects of levetiracetam in epilepsy: An open-label multicenter study. Epilepsy Behav 2009, 16:468-474.